OSCR

Oscar Health, Inc. (OSCR) | Rumor.io

Oscar Health

OSCR

Attention (50-day avg)0.09%

Attention rank (50-day avg)#106

Bullish sentiment (50-day avg)97%

Price to earnings ratio22.8

Market capitalization9.2B

Earnings per share1.3

Dividend yield (TTM)—

Revenue (annual)11.7B

Net income (annual)-442.9M

Social

What share of all stock conversation is about OSCR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0.05% +0.02	0.06% -0.03	0.09% -0.04	0.12% -0.18

Sep 29

Oscar Health's investor day was a significant event, with a video breakdown of the 2024-2026 investor day guide being crushed, and a 2027-2029 investor day guide expected to be crushed again.
The company's operating leverage is showing up, with SG&A falling to 14.2% of revenue from 18.7%, and the operating margin swinging from -8% to +8%.
Oscar Health is trying to build more than just a health insurer, with its health marketplace, Lucie, designed to give consumers more choice and make it easier to shop for healthcare.

Generated by AI

Sentiment

Of the messages about OSCR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	99.4% -0.6	84.6% -12.03	93.96% +3.36	91.91% +0.16
Bearish	0.6% new	15.4% +12.03	6.04% -3.36	8.09% -0.16

Bullish· Sep 29

Oscar Health's growth is not reflected in its stock price, with a P/S ratio of 0.485x compared to slower-growing health insurance giants.
The company's investor day was a successful event, with a 2029 EPS guide of $X.XX, indicating strong growth potential.
Oscar Health has made significant improvements in its operating leverage, with SG&A falling to 14.2% of revenue and operating margin swinging to +8% from -8%.

Bearish· Aug 6

The stock price of Oscar Health ($OSCR) has dropped nearly 30% from pre-market highs, with some users attributing this to the market's knowledge of upcoming GAAP-negative quarters.
Oscar Health's earnings have been impacted by a surge in medical costs, with a 18.5% increase in per-member costs, driven by a new member utilization surge that may be a one-off event.
Despite beating EPS by 189% and delivering "crushing" earnings, the stock price of Oscar Health has dropped significantly, with some users attributing this to a rise in medical care costs and lowering of CY MLR projections.

Generated by AI

Topics

Of the messages about OSCR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	0%	1.4%	42.28%	13.06%
Announcements	2.35%	10.22%	2.56%	10.61%
Technical Analysis	97.65%	54.92%	13.92%	27.55%
Earnings	0%	0%	0.78%	6.92%
Macro	0%	33.46%	40.45%	41.77%
Controversies	0%	0%	0%	0.08%

Earnings· Aug 6

Oscar Health's Q2 2026 earnings beat expectations, with revenue of $4.9B, EPS of $1.10, and adjusted EBITDA of $415.3M, significantly higher than estimated.
The company raised its full-year 2026 guidance, with revenue expected to be $18.7B-$19.0B and operating income of $500M-$700M.
Despite the strong earnings, Oscar Health's stock price reversed significantly, falling from a 15% pre-market gain to a 4% decline, raising questions about the sustainability of the company's margins.

Analysts· Sep 17

Barclays upgrades Oscar Health's price target to $49 from $39, maintaining an Overweight rating.
Several analysts, including Baird and Bank of America, also raise their price targets on Oscar Health following the company's Investor Day.
Analysts at Barclays, Piper Sandler, and Baird see Oscar Health's 2029 targets as achievable, with Barclays having one of the highest price targets on the Street.

Announcements· Aug 6

Oscar Health reports record financial results for the first half of 2026, with revenue of $18.7B-$19.0B and operating income of $500M-$700M, beating estimates and raising full-year guidance.
The company's Q2 earnings print was a "masterclass in underwriting discipline and operating leverage," with EPS beating consensus by $1.10 and Adjusted EBITDA of $415.3M crushing estimates by $227.3M.
Oscar Health's aggressive pricing strategy has successfully altered the company's trajectory, with revenue surging 70% YoY to $4.88B and profitability reaching record levels, despite shares being down 9.3% following the earnings release.

Controversies· May 18

Oscar Health, Inc. (OSCR) is facing a securities class action lawsuit, with a deadline of July 11, 2022, for investors to secure counsel.
Several law firms have issued press releases, encouraging investors with losses to contact them before the deadline, including Pomerantz Law Firm, Rosen, a top ranked law firm, and The Schall Law Firm.
The class action lawsuit against Oscar Health, Inc. is reportedly related to the company's securities, with one press release stating that former Louisiana Attorney General Kahn is involved in the investigation.

Technical Analysis· Aug 6

The technical structure of Oscar Health, Inc. ($OSCR) and another stock ($ADUR) looks remarkably similar, with $OSCR already confirming its breakout and delivering a massive +260% move, while $ADUR is still consolidating inside an Ascending Triangle after completing a classic Cup and Handle pattern.
The key level to watch for $OSCR is the $18 resistance, which could trigger a quick upside move if buyers take control above that level; the chart is also worth keeping on the watchlist for a potential breakout.
Oscar Health, Inc. ($OSCR) is expected to break out above the $21.87 to $23.56 zone, which was its previous resistance and is now aligned with the volume profile, making it an important area to watch.

Generated by AI

Community

Of the messages about OSCR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	99.5%	79.27%	66.72%	82.15%
Newcomers	0.5%	20.73%	33.28%	17.85%

Regulars· Sep 29

The market's current price level for $OSCR is seen as a reminder of the full impulse count, with the same targets and chart as shared nearly 2 years ago, and all dips being opportunities to add to the position.
Oscar Health's investor day was a significant event, with the 2024-2026 investor day guide being crushed, and the 2027-2029 guide expected to be similarly impressive, making being an $OSCR shareholder easy.
The company's operating leverage is showing up, with SG&A falling to 14.2% of revenue from 18.7%, and the operating margin swinging from -8% to +8%, which is the type of improvement that matters more than the stock price.

Newcomers· Sep 24

Newcomers are focusing on the technical analysis of Oscar Health, Inc. ($OSCR), with some users noting its recent bounce back after hitting the 50 EMA near $30.50.
Others are buying shares of $OSCR at its current price, with one user scooping up 1,770 shares at $28.52, anticipating a potential gain.
The company's recent announcement of CMS-confirmed disenrollments of 8-10% of its marketplace members due to program integrity initiatives and fraud enforcement is also being discussed among newcomers.

Generated by AI

Oscar Health (OSCR) has drawn fresh attention after management highlighted a roadmap to higher earnings per share, tied to medical loss ratio discipline and new offerings such as the Lucy Healthcare Marketplace and AI powered tools. Recent trading has been choppy for Oscar Health, with the share price slipping 5.40% over seven days and 2.86% over 30 days. However, a 3.79% 90 day share price return and a 97.73% year to date share price return suggest momentum has been building over a longer...

2d agoYahoo Finance

Oscar Health (OSCR) Stock Looks Cheap Relative To Its Earnings Path

Oscar Health has been on a powerful run in recent years, yet the real question for you today is whether the current share price lines up with what its earnings story can reasonably support. The stock has also seen shorter term pullbacks, which makes the earnings backdrop even more important for anyone trying to judge what they are actually paying for. Over the past 3 years the stock has delivered a very large gain of about 4.3x, which puts a lot of weight on whether the underlying earnings...

2d agoYahoo Finance

Oscar Health director Vanessa Wittman sells $806,000 in stock

3d agoInvesting.com

Oscar Health Stock: Market Share Gains Are Only Part Of The Plan (NYSE:OSCR)

Oscar Health (OSCR) buy thesis: $45–$49 fair value on ACA growth, improving margins and Lucie upside.

3d agoSeeking Alpha

Can Oscar Health Sustain Its Profit Rebound as Medical Costs Rise?

Oscar Health's profit rebound faces a test as rising medical spending and a larger member base threaten second-half profitability.

6d agoYahoo Finance

All You Need to Know About Oscar Health (OSCR) Rating Upgrade to Strong Buy

Oscar Health (OSCR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

6d agoYahoo Finance

Also Discussed

Investors talking about OSCR also mention

#	Name	Attention
1	Hims & Hers Health, Inc.HIMS	0.17%+0.1
2	UnitedHealth Group IncorporatedUNH	0%-0.02
3	Zeta Global Holdings Corp.ZETA	0%-0.03
4	dLocal LimitedDLO	0%new
5	Centene CorpCNC	0%0
6	Elevance Health, Inc.ELV	0%new
7	Cipher Digital Inc.CIFR	0.19%-0.62
8	Nebius Group N.V. Class A Ordinary SharesNBIS	0.93%-0.15
9	Novo Nordisk A/S Sponsored ADRNVO	0.14%-0.04
10	Lemonade Inc.LMND	0%new

Oscar Health, Inc.

Healthcare
Healthcare Plans

Oscar Health, Inc. is a health insurance and healthcare technology company headquartered in New York, founded in 2012. The company focuses on delivering health coverage through a technology-driven, full-stack platform designed to simplify the healthcare experience for members. Oscar Health offers Individual & Family plans, small group coverage, and solutions tailored to Individual Coverage Health Reimbursement Arrangements (ICHRA), serving consumers, employers, and other organizations across various U.S. markets. Through its +Oscar technology services, the company provides infrastructure and tools to other payors and providers, enabling data-driven care management, member engagement, and plan administration. Oscar Health also operates the Lucie Health Marketplace, a platform that helps consumers compare and select health plans and related services, enhancing choice and transparency. Across its offerings, the company emphasizes intuitive digital engagement, virtual care access, and coordination with high-value clinical providers, positioning Oscar Health as a distinctive player in the managed health care and insurtech segments.

Website

Location

75 Varick Street

New York, NY, 10013

United States

Social

What share of all stock conversation is about OSCR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0.05% +0.02	0.06% -0.03	0.09% -0.04	0.12% -0.18

Sep 29

Oscar Health's investor day was a significant event, with a video breakdown of the 2024-2026 investor day guide being crushed, and a 2027-2029 investor day guide expected to be crushed again.
The company's operating leverage is showing up, with SG&A falling to 14.2% of revenue from 18.7%, and the operating margin swinging from -8% to +8%.
Oscar Health is trying to build more than just a health insurer, with its health marketplace, Lucie, designed to give consumers more choice and make it easier to shop for healthcare.

Generated by AI

Sentiment

Of the messages about OSCR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	99.4% -0.6	84.6% -12.03	93.96% +3.36	91.91% +0.16
Bearish	0.6% new	15.4% +12.03	6.04% -3.36	8.09% -0.16

Bullish· Sep 29

Oscar Health's growth is not reflected in its stock price, with a P/S ratio of 0.485x compared to slower-growing health insurance giants.
The company's investor day was a successful event, with a 2029 EPS guide of $X.XX, indicating strong growth potential.
Oscar Health has made significant improvements in its operating leverage, with SG&A falling to 14.2% of revenue and operating margin swinging to +8% from -8%.

Bearish· Aug 6

The stock price of Oscar Health ($OSCR) has dropped nearly 30% from pre-market highs, with some users attributing this to the market's knowledge of upcoming GAAP-negative quarters.
Oscar Health's earnings have been impacted by a surge in medical costs, with a 18.5% increase in per-member costs, driven by a new member utilization surge that may be a one-off event.
Despite beating EPS by 189% and delivering "crushing" earnings, the stock price of Oscar Health has dropped significantly, with some users attributing this to a rise in medical care costs and lowering of CY MLR projections.

Generated by AI

Topics

Of the messages about OSCR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	0%	1.4%	42.28%	13.06%
Announcements	2.35%	10.22%	2.56%	10.61%
Technical Analysis	97.65%	54.92%	13.92%	27.55%
Earnings	0%	0%	0.78%	6.92%
Macro	0%	33.46%	40.45%	41.77%
Controversies	0%	0%	0%	0.08%

Earnings· Aug 6

Oscar Health's Q2 2026 earnings beat expectations, with revenue of $4.9B, EPS of $1.10, and adjusted EBITDA of $415.3M, significantly higher than estimated.
The company raised its full-year 2026 guidance, with revenue expected to be $18.7B-$19.0B and operating income of $500M-$700M.
Despite the strong earnings, Oscar Health's stock price reversed significantly, falling from a 15% pre-market gain to a 4% decline, raising questions about the sustainability of the company's margins.

Analysts· Sep 17

Barclays upgrades Oscar Health's price target to $49 from $39, maintaining an Overweight rating.
Several analysts, including Baird and Bank of America, also raise their price targets on Oscar Health following the company's Investor Day.
Analysts at Barclays, Piper Sandler, and Baird see Oscar Health's 2029 targets as achievable, with Barclays having one of the highest price targets on the Street.

Announcements· Aug 6

Oscar Health reports record financial results for the first half of 2026, with revenue of $18.7B-$19.0B and operating income of $500M-$700M, beating estimates and raising full-year guidance.
The company's Q2 earnings print was a "masterclass in underwriting discipline and operating leverage," with EPS beating consensus by $1.10 and Adjusted EBITDA of $415.3M crushing estimates by $227.3M.
Oscar Health's aggressive pricing strategy has successfully altered the company's trajectory, with revenue surging 70% YoY to $4.88B and profitability reaching record levels, despite shares being down 9.3% following the earnings release.

Controversies· May 18

Oscar Health, Inc. (OSCR) is facing a securities class action lawsuit, with a deadline of July 11, 2022, for investors to secure counsel.
Several law firms have issued press releases, encouraging investors with losses to contact them before the deadline, including Pomerantz Law Firm, Rosen, a top ranked law firm, and The Schall Law Firm.
The class action lawsuit against Oscar Health, Inc. is reportedly related to the company's securities, with one press release stating that former Louisiana Attorney General Kahn is involved in the investigation.

Technical Analysis· Aug 6

The technical structure of Oscar Health, Inc. ($OSCR) and another stock ($ADUR) looks remarkably similar, with $OSCR already confirming its breakout and delivering a massive +260% move, while $ADUR is still consolidating inside an Ascending Triangle after completing a classic Cup and Handle pattern.
The key level to watch for $OSCR is the $18 resistance, which could trigger a quick upside move if buyers take control above that level; the chart is also worth keeping on the watchlist for a potential breakout.
Oscar Health, Inc. ($OSCR) is expected to break out above the $21.87 to $23.56 zone, which was its previous resistance and is now aligned with the volume profile, making it an important area to watch.

Generated by AI

Community

Of the messages about OSCR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	99.5%	79.27%	66.72%	82.15%
Newcomers	0.5%	20.73%	33.28%	17.85%

Regulars· Sep 29

The market's current price level for $OSCR is seen as a reminder of the full impulse count, with the same targets and chart as shared nearly 2 years ago, and all dips being opportunities to add to the position.
Oscar Health's investor day was a significant event, with the 2024-2026 investor day guide being crushed, and the 2027-2029 guide expected to be similarly impressive, making being an $OSCR shareholder easy.
The company's operating leverage is showing up, with SG&A falling to 14.2% of revenue from 18.7%, and the operating margin swinging from -8% to +8%, which is the type of improvement that matters more than the stock price.

Newcomers· Sep 24

Newcomers are focusing on the technical analysis of Oscar Health, Inc. ($OSCR), with some users noting its recent bounce back after hitting the 50 EMA near $30.50.
Others are buying shares of $OSCR at its current price, with one user scooping up 1,770 shares at $28.52, anticipating a potential gain.
The company's recent announcement of CMS-confirmed disenrollments of 8-10% of its marketplace members due to program integrity initiatives and fraud enforcement is also being discussed among newcomers.

Generated by AI

Oscar Health

Social

Sep 29

Bullish· Sep 29

Bearish· Aug 6

Earnings· Aug 6

Analysts· Sep 17

Announcements· Aug 6

Controversies· May 18

Technical Analysis· Aug 6

Regulars· Sep 29

Newcomers· Sep 24

Is Oscar Health (OSCR) Cheap After Its EPS Roadmap And New Product Push?

Oscar Health (OSCR) Stock Looks Cheap Relative To Its Earnings Path

Oscar Health director Vanessa Wittman sells $806,000 in stock

Oscar Health Stock: Market Share Gains Are Only Part Of The Plan (NYSE:OSCR)

Can Oscar Health Sustain Its Profit Rebound as Medical Costs Rise?

All You Need to Know About Oscar Health (OSCR) Rating Upgrade to Strong Buy

Also Discussed

Oscar Health, Inc.

Company Information

Location

Is Oscar Health (OSCR) Cheap After Its EPS Roadmap And New Product Push?

Oscar Health (OSCR) Stock Looks Cheap Relative To Its Earnings Path

Oscar Health director Vanessa Wittman sells $806,000 in stock

Oscar Health Stock: Market Share Gains Are Only Part Of The Plan (NYSE:OSCR)

Can Oscar Health Sustain Its Profit Rebound as Medical Costs Rise?

All You Need to Know About Oscar Health (OSCR) Rating Upgrade to Strong Buy

Also Discussed

Social

Sep 29

Bullish· Sep 29

Bearish· Aug 6

Earnings· Aug 6

Analysts· Sep 17

Announcements· Aug 6

Controversies· May 18

Technical Analysis· Aug 6

Regulars· Sep 29

Newcomers· Sep 24